Cindy Alvarez

Cindy Alvarez is an accomplished regulatory affairs professional with extensive experience in the biotechnology and pharmaceutical industries. Currently serving as Senior Director of Regulatory Affairs at CG Oncology, Alvarez has previously held notable positions at SillaJen as Director of Regulatory Affairs and as a Regulatory Affairs Consultant for both Denali Therapeutics and Opus Regulatory Inc. Additional experience includes regulatory consulting roles at Genentech and Onyx Pharmaceuticals, where Alvarez contributed significantly to high-profile FDA submissions and clinical efficacy reviews. Notably, a background in academia includes serving as Adjunct Faculty at The George Washington University, where instruction focused on regulatory strategy for drug and biologics development. Alvarez holds a Master of Science in Health Sciences with a focus on Regulatory Affairs and Clinical Leadership from The George Washington University and a Bachelor of Science in Biological Sciences from UC Irvine.